TP53 and neoplasm: In this series, we have shown previously that premenopausal node-negative breast cancer patients whose tumours show p53 accumulation have a poor response to one cycle of adjuvant chemotherapy, whereas patients whose tumours have no accumulation of p53 benefit from adjuvant chemotherapy.